Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Veterans Affairs was posted on March 12, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Mutli-station Radiopharmaceutical Purchase (Phx, Tucson)

Closed
36C25821Q0109Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

in 12 days

General Info

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

AZ

Set-Aside

NONE

Award Issued Date

Documents

6

36C25821Q0109+0001_1.docx

DOCX

36C25821Q0109+0001.pdf

PDF

36C25821Q0109_1.docx

DOCX

36C25821Q0109.pdf

PDF

Attachment+1+Contract+Price+List.xlsx

XLSX

Radiopharmaceutical+Delivery+-+Vendor+Questions.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 258-NETWORK Cntrct Office 22G (36C258)
Contacts1 person available
OfficeMESA, AZ, 85212, USA
Office AddressMESA, AZ, 85212, USA
Contacts

Full Description

Show more
The purpose of this amendment is to provide answers to vendor questions and correct the price/cost schedule.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS